Announcement on Change of Chief Financial Officer
Filed with SSE · · 2 pages · Chinese
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. on 6ix
Earlier from Shanghai Fosun Pharmaceutical (Group)
- Announcement on Participating in Setting up Private Equity Investment Fund
- Announcement on Proposed Expansion of Financial Leasing Business by a Holding Subsidiary
- Announcement on Resolutions of the Convening of the 2026 1st Extraordinary General Meeting, the 2026 1st A-share General Meeting and the 2026 1st H-share General Meeting
- Self-Inspection Report on Trading of the Company's Shares by Insiders Related to the Spin-off and Listing of a Subsidiary on the Main Board of the Stock Exchange of Hong Kong Limited
- Announcement on Progress in Signing the Licensing Agreement of Wholly-owned Subsidiary
Later from Shanghai Fosun Pharmaceutical (Group)
- Announcement on Approval of Supplementary Drug Application by Holding Subsidiary
- Announcement on the Pledge of Partial Shares Held by Shareholders
- Fosun Health เสริมความแกร่งระดับภูมิภาคที่ GlobalHealth Asia-Pacific Forum 2026 อวด "China Solution" พร้อมกวาดสามรางวัลใหญ่
- Announcement on Progress in Participation in Establishing a Private Equity Investment Fund and Proposed Disposal of Assets
- Arcera Life Sciences and Fosun Pharma launch long-term collaboration framework
Follow Shanghai Fosun Pharmaceutical (Group) into a list and get an email when it puts out news.
Follow Shanghai Fosun Pharmaceutical (Group)